PEDRO
PÉREZ SEGURA
Profesor asociado de Ciencias de la Salud
PEDRO PÉREZ SEGURA-rekin lankidetzan egindako argitalpenak (7)
2024
-
Response to Yilmaz et al.
Anti-Cancer Drugs
2023
-
Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck
Cancers, Vol. 15, Núm. 9
-
Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer
Anti-Cancer Drugs, Vol. 34, Núm. 5, pp. 695-698
-
Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer
Oncology Letters, Vol. 25, Núm. 1
2022
2021
-
Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer
Oncologist, Vol. 26, Núm. 6, pp. e1018-e1035
2019
-
Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer
Head and Neck, Vol. 41, Núm. 6, pp. E86-E92